Boston Scientific Announces Results For Third Quarter 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
- Devon Energy to sell Eagle Ford assets to Crescent Energy for $4.2B
Boston Scientific (BSX) Top Rating Maintained at Needham & Company Despite Mixed Qtr
October 24, 2018 12:52 PM EDTNeedham & Company analyst Mike Matson reiterated a Strong Buy and $43 price target on Boston Scientific (NYSE: BSX) as revenue missed consensus due to currency while its EPS beat consensus. Meanwhile, management lowered its revenue guidance due to currency and narrowed its EPS guidance.
Matson... More
Boston Scientific (BSX) Tops Q3 EPS by 1c, Updates Guidance
October 24, 2018 6:33 AM EDTBoston Scientific (NYSE: BSX) reported Q3 EPS of $0.35, $0.01 better than the analyst estimate of $0.34. Revenue for the quarter came in at $2.39 billion versus the consensus estimate of $2.4 billion.
GUIDANCE:
Boston Scientific sees FY2018 EPS of $1.38-$1.40, versus the consensus of $1.40.... More



